Symposium 5302: What to Do When Everything Fails: Treatment Options for Severe Chronic Rhinosinusitis
AMA PRA Category 1 Credits^TM: 1.25
CE: 1.50

Upon completion of this session, participants should be able to:

• Contrast the limitations and possibilities of high-dose or long-lasting glucocorticosteroid treatment in recurrent chronic rhinosinusitis with nasal polyps.
• Identify suitable patient subgroups, success rates and limitations of aspirin desensitization.
• Outline the pathophysiological basis and current knowledge about anti-IgE and anti-IL-5 treatment in nasal polyposis.

Credit must be claimed by May 31, 2016. Any credit request on or after June 1, 2016 will be subject to an administrative fee.